Format your manuscript to the Journal of Immunotherapy requirements — abstract, numbered Vancouver (superscript in text) references, and required declarations — and submit through Editorial Manager without a formatting rejection.
4.7
Authored by Sumalatha Gangadhar | Published on 19 August, 2026
Getting past the desk at Journal of Immunotherapy is usually less about the research and more about matching the journal’s exact submission rules. This template is built around Journal of Immunotherapy’s actual requirements — its abstract rules, numbered Vancouver (superscript in text) references, and the required declarations — so your submission clears screening on the first pass. Everything below tracks the Journal of Immunotherapy author guidelines; check it directly if anything looks out of date by the time you submit.
It’s a manuscript shell set up to Journal of Immunotherapy’s specifications for the immunotherapy of cancer — cellular therapies, vaccines, checkpoint inhibitors, and translational immunology. Journal of Immunotherapy is published by Wolters Kluwer (Lippincott). The shell covers the title page, the abstract, a body in Introduction, Methods, Results, and Discussion (IMRaD) order, and a reference list in numbered Vancouver (superscript in text) style.
Start with the title page (authors, affiliations, and ORCID iDs). The abstract is a structured abstract of ≤250 words. The body follows Introduction, Methods, Results, and Discussion (IMRaD), and the reference list uses numbered Vancouver (superscript in text). Close with the declarations block: conflict of interest, funding, ethics approval and consent, and data availability.
Beyond that, match your article type’s specific limits rather than assuming the defaults apply, keep numbered Vancouver (superscript in text) formatting consistent from the first draft, and submit only through Editorial Manager — email submissions aren’t processed.
The shell mirrors what Journal of Immunotherapy’s editorial staff check first: abstract format and length, numbered Vancouver (superscript in text) reference formatting, and a complete declarations block. For the journal’s full aims and scope, see the Journal of Immunotherapy journal home page. Journal of Immunotherapy offers an open-access option; check the current article-processing charge and any waiver before you commit. Manuscripts go in through Editorial Manager, which also tracks your paper through peer review.
| Element | Journal of Immunotherapy requirement |
|---|---|
| Abstract | a structured abstract of ≤250 words |
| Main text | Introduction, Methods, Results, and Discussion (IMRaD) |
| Declarations | Conflict of interest, funding, ethics approval and consent, and data availability |
| Figures / tables | Captioned, cited in order; check format and resolution rules in the guide |
| Supplemental | Large datasets, extra tables, code — uploaded separately and cited in text |
| Submission | editorialmanager.com/ji |
Read the Journal of Immunotherapy author guidelines once before drafting and once before upload. Draft the abstract after your results are stable so it matches the paper. Set numbered Vancouver (superscript in text) as your reference style before adding a single citation — retrofitting it later is where errors creep in.
Skim two or three recent Journal of Immunotherapy papers to calibrate depth, structure, and figure style. State your contribution in the first two paragraphs, not on page ten. Write a data-availability statement that names a real repository rather than a placeholder, and disclose any preprint or conference version with identifiers in your cover letter. Confirm current open-access pricing and any institutional agreement before committing to a fee.
Do one focused pass against the Journal of Immunotherapy author guidelines: scope fit, abstract format, length, numbered Vancouver (superscript in text) references, required declarations, and figure quality. Then submit through Editorial Manager.